Club Top 10 to Watch Monday, November 17th 1. Stock futures are relatively calm this morning. Markets are coming off a volatile week with doubts over the sustainability of AI spending and whether a December rate cut is still on the table. 2. Morgan Stanley downgraded Dell two notches to sell due to concerns that a memory price supercycle could hurt profit margins. Meanwhile, Morgan Stanley also downgraded HP’s rating. Hewlett-Packard Enterprise is selling the company, and Hewlett-Packard Enterprise is owning it. 3. The Financial Times reported Friday that Apple’s longtime CEO Tim Cook may step down next year. John Tarnas, Apple’s senior vice president of hardware engineering, is considered a possible successor, the report said. Shares in Apple, the club’s name, have fallen more than 1% since early this morning. 4. Barclays analysts upgraded Gap from Hold to Buy, citing the retailer’s ability to absorb tariff pressure. The company also liked its strong back-to-school season. We own the TJX company. 5. TD Cowen upgraded Yum Brands from Hold to Buy and raised its price target from $162 to $173. Analysts say a sale of struggling restaurant giant Pizza Hut would help improve the company’s growth profile. 6. The club that owns Boeing has won a 777x order from Emirates Airlines worth $38 billion. That’s a good sign of demand for struggling U.S. aircraft makers. 7. BMO Capital on Wednesday evening raised its price target on Palo Alto Networks from $225 to $230 ahead of quarterly results. Analysts at the firm maintained their Buy rating on the stock, insisting that cybersecurity remains an attractive investment. The club’s other cyber stock is CrowdStrike. 8. Bank of America raised Snowflake’s price target from $280 to $310 ahead of earnings in early December. The company also maintained a buy rating on the stock. 9. Johnson & Johnson announced plans to acquire cancer drug developer Hulda Therapeutics for $3.05 billion in cash. This is another sign of increased M&A activity in the biotech space. Earlier this year, Johnson & Johnson acquired nerve drug maker Intracellular Therapies for $14.6 billion. 10. Novo Nordisk is lowering the price of its obesity drug for cash-paying patients. Although the new prices are lower than Eli Lilly’s, the club still has superior drugs that should command a premium. Sign up for free for my Top 10 Morning Thoughts on the Markets email newsletter (See here for a complete list of Jim Cramer Charitable Trust stocks.) As a subscriber to Jim Cramer’s CNBC Investment Club, you’ll receive trade alerts before Jim makes a trade. After Jim sends a trade alert, he waits 45 minutes before buying or selling stocks in his charitable trust’s portfolio. If Jim talks about a stock on CNBC TV, he will issue a trade alert and then wait 72 hours before executing the trade. The above investment club information is subject to our Terms of Use and Privacy Policy, along with our disclaimer. No fiduciary duties or obligations exist or arise from your receipt of information provided in connection with the Investment Club. No specific results or benefits are guaranteed.
